# If Danaher Corporation moves, who benefits? How far does the value-chain ripple reach?
Canonical: https://valuechain.wiki/danaher · Facet: ripple · Updated: 2026-10-09T20:24:05.807+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Per the valuechain.wiki graph, Danaher Corporation is directly linked to 2 companies (0 supply, 2 revenue relationships) and reaches 8 companies within two hops; the links are backed by 11 dated sources, 5 of them primary filings (as of 2026-10-09).

Danaher Corporation operates across Life-Science Tools, S&P 500. It is -8.9% in 2026. The stock (-8.9%) and its demand side (avg -17.1%) are moving in step. Bioprocessing demand recovered in 2025, lifting Biotechnology segment revenue 8.0%.

## Demand chain (leading)
- T1 Samsung Biologics (https://valuechain.wiki/samsung-biologics.md)
- T2 LigaChem Biosciences (https://valuechain.wiki/ligachem-biosciences.md)
- T3 Johnson & Johnson (https://valuechain.wiki/johnson-johnson.md)
- T3 Amgen (https://valuechain.wiki/amgen.md)
- T2 Gilead Sciences, Inc. (https://valuechain.wiki/gilead-sciences.md)
- T3 Cencora, Inc. (https://valuechain.wiki/cencora.md)
- T3 McKesson Corporation (https://valuechain.wiki/mckesson.md)
- T3 Cardinal Health, Inc. (https://valuechain.wiki/cardinal-health.md)
- T2 Pfizer Inc. (https://valuechain.wiki/pfizer.md)
- T2 Bristol-Myers Squibb Company (https://valuechain.wiki/bristol-myers-squibb.md)
- T3 ABL Bio (https://valuechain.wiki/abl-bio.md)
- T3 Regeneron Pharmaceuticals (https://valuechain.wiki/regeneron-pharmaceuticals.md)
- T1 Moderna (https://valuechain.wiki/moderna.md)
- T2 Merck & Co. (https://valuechain.wiki/merck-co.md)
- T2 Vertex Pharmaceuticals Incorporated (https://valuechain.wiki/vertex-pharmaceuticals.md)

---
Full node: https://valuechain.wiki/danaher.md · JSON: https://valuechain.wiki/danaher.json